04083nam 2200685 450 991013911760332120200520144314.01-118-85586-81-118-85601-51-118-85604-X(CKB)2550000001277691(EBL)1676383(SSID)ssj0001216013(PQKBManifestationID)11647663(PQKBTitleCode)TC0001216013(PQKBWorkID)11190219(PQKB)11590652(OCoLC)880451437(MiAaPQ)EBC1676383(DLC) 2014006433(Au-PeEL)EBL1676383(CaPaEBR)ebr10862682(CaONFJC)MIL599755(OCoLC)878111053(PPN)200125826(EXLCZ)99255000000127769120140501h20142014 uy 0engur|n|---|||||txtccrHandbook of nanotoxicology, nanomedicine and stem cell use in toxicology /Saura C. Sahu, Daniel A. Casciano, editorsFirst edition.West Sussex, England :John Wiley & Sons,2014.©20141 online resource (441 p.)Description based upon print version of record.1-118-43926-0 1-306-68504-4 Includes bibliographical references and indexes.Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology; Contents; Contributors; Preface; Acknowledgments; Dedication; Abbreviations and Acronyms; Part One Nanotoxicology; Chapter 01 Testing Nanotoxicity: An Update of New and Traditional Methods; Chapter 02 Considerations for In Vitro Nanotoxicity Testing; Chapter 03 In Vivo Evaluation of Acute and Chronic Nanotoxicity; Chapter 04 Genotoxicity of Silver Nanoparticles; Chapter 05 Immunotoxicology of Nanomaterials; Chapter 06 Neurotoxicity of NanoparticlesChapter 07 Nanoparticles and Plants: From Toxicity to Activation of GrowthChapter 08 Epigallocatechin-3-gallate (EGCG) in or on Nanoparticles: Enhanced Stability and Bioavailability of EGCG Encapsulated in Nanoparticles or Targeted Delivery of Gold Nanoparticles Coated with EGCG; Part Two Nanomedicine; Chapter 09 Factors Affecting the Oral Bioavailability of Nanomaterials; Chapter 10 Nanomedicine in Cancer Treatment; Chapter 11 Nanomedicine in Diabetes: Using Nanotechnology in Prevention and Management of Diabetes MellitusChapter 12 Inhalation Pathway as a Promising Portal of Entry: What Has to Be Considered in Designing New Nanomaterials for Biomedical Application?Chapter 13 Nanomedicine for the Brain and the Eye: Disease Management in Poorly Accessible Compartments of the Body; Part Three Stem Cell Toxicology; Chapter 14 Stem Cells in Toxicity Testing; Chapter 15 Human Stem-Cell-Derived Cardiomyocytes in Drug Discovery and Toxicity Testing; Chapter 16 Pluripotent Stem Cells as Tools to Assess Developmental Toxicity: Diversity Instead of ConsolidationChapter 17 Impact of Various Nanosystems on Stem Cell PhysiologyChapter 18 Predictive Mechanisms in Stem Cells: An In Vitro System-Based Method for Testing Carcinogenicity; Chapter 19 Epigenetic Modifications and Stem Cell Toxicology: Searching for the Missing Link; Chapter 20 Epigenetic Modeling and Stem Cells in Toxicology Testing; Chapter 21 Use of Video Bioinformatics Tools in Stem Cell Toxicology; Author Index; Subject IndexHandbook of Nanomedicine and NanotoxicologyNanoparticlesToxicologyNanostructured materialsToxicologyNanoparticlesToxicology.Nanostructured materialsToxicology.615.1901Sahu Saura C.Casciano Daniel A.MiAaPQMiAaPQMiAaPQBOOK9910139117603321Handbook of nanotoxicology, nanomedicine and stem cell use in toxicology1994542UNINA